Karl Thor
Signal active
Chief Scientific Officer
Contact Information
Social
Primary Organization
Dignify Therapeutics
Founded
2013
Employees
1-10
Industry
Biotechnology, Health Care, Pharmaceutical, Therapeutics
Bio
Karl Thor, PhD was most recently Co-founder and VP of Research of Urogenix Inc., a subsidiary of Astellas Pharma. Prior to that, he was Founder and CSO of Dynogen Pharmaceuticals, Founder and CSO of PPD GenuPro, Co-Director of the Laboratory of NeuroUrology at Duke University Medical Center, and Research Scientist at Eli Lilly. Dr. Thor has served as a member of the FDA-PhRMA Industry Guidelines for Urinary Incontinence Trials, the NIH Urology Special Emphasis Study Section, and serves on the WHO’s International Consultation on Incontinence.
Location
Raleigh, North Carolina, United States, North America
Jobs history
0
N/A
Board and Advisor Roles
0
N/A
Educations
1
N/A
Profile Resume
Karl Thor is the Chief Scientific Officer at Dignify Therapeutics, based in United States, North America. With a background in Biotechnology, Karl Thor has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Products and Innovations
0
There is no product and inovations for this profile.
Achievements
0
There is no Achievements for this profile.
Publications
0
There is no publication for this profile.
Recent Activity